N/a Injection, Solution
Product Images NDC 71053-595

5 FDA label images from Rafa Laboratories, Ltd. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for N/a (NDC 71053-595). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rafa Laboratories, Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aes Clinical Trials (Pi Table1)

Aes Clinical Trials (Pi Table1)
A table comparing adverse reaction percentages between IM Midazolam (N=448) and IV Lorazepam (N=445). It lists adverse reactions including upper airway obstruction, agitation, pyrexia, mental status changes, postictal state, and acute renal failure, showing higher occurrence rates for IM Midazolam across all listed categories.*
FDA Label Image

Structure (Midazolam Structure)

Structure (Midazolam Structure)
Chemical structure diagram of Midazolam, showing its molecular framework with chlorine and fluorine substituted aromatic rings and fused nitrogen-containing rings.*
FDA Label Image

Tactile Change Ifu (Nda 216359 Suppl 2 Ifu Approved Page 1)

Tactile Change Ifu (Nda 216359 Suppl 2 Ifu Approved Page 1)
Instructions for use of Midazolam Injection 10 mg/0.7 mL autoinjector for intramuscular administration. The text covers criteria for use in status epilepticus based on patient age and seizure type with a flowchart. Step-by-step instructions with illustrations show removing the autoinjector from its plastic sleeve, holding it properly, and removing the grey safety cap. The content emphasizes that only trained individuals should administer and that autoinjectors are single-use only.*
FDA Label Image

Tactile Change Ifu_2 (Nda 216359 Suppl 2 Ifu Approved Page 2)

Tactile Change Ifu_2 (Nda 216359 Suppl 2 Ifu Approved Page 2)
This instructional panel for Midazolam Injection, 10 mg intramuscular autoinjector by Rafa Laboratories, Ltd., details steps for proper injection at the mid-outer thigh. It includes illustrations showing the injection site, guidance on holding the autoinjector for at least 10 seconds, verifying needle visibility after injection, massaging the site, and safe disposal by bending the needle and pinning the autoinjector to clothing. It emphasizes single-dose use and monitoring respiratory and cardiac function post-administration.*
FDA Label Image

480 Count Box (Box Label)

480 Count Box (Box Label)
Label for Midazolam Injection 10 mg/0.7 mL autoinjector solution for intramuscular use. Each autoinjector delivers 10 mg Midazolam with hydrochloric acid and sodium chloride. Contains 480 single-dose autoinjectors. Manufactured by Rafa Laboratories, Jerusalem, Israel. Includes NDC 71053-595-01 and storage instructions to avoid freezing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.